Clin2
NCT07824973Likely a fitNot yet recruiting

How ketamine results are described for treatment-resistant depression

Treatment Resistant Depression (TRD)

Part of Mental health clinical trials.

This study looks at how the way ketamine treatment is described or presented (called 'framing') might affect its results for people with depression that hasn't improved with other treatments. If you're already getting ketamine for depression, this trial may help you and others understand more about your treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must already be prescribed ketamine treatment for depression.
  • You need to be able to understand the study details and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06668571Recruiting· Phase 2
Ketamine for treatment-resistant depression

This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.

Rochester, Minnesota
NCT07247006Not yet recruiting· Phase 2
Ketamine therapy for hard-to-treat depression

This study tests whether ketamine, given with talk therapy, can help people whose depression hasn't improved with at least two antidepressants. It aims to see if this combination can reduce depression symptoms.

Rochester, New York
NCT07307768Not yet recruiting· Phase 1
Ketamine treatment study for severe major depression

This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.

New York, New York
NCT05915013Recruiting· Phase 1
Brain-targeting study of ketamine response in treatment-resistant depression

This early-stage study looks at how parts of brain cells respond to ketamine in people with depression who have not improved with usual antidepressants. It may help researchers find why ketamine works for some people and not others, and who might benefit.

New Haven, Connecticut
NCT06480201Recruiting· Phase 1
Ketamine for treatment-resistant depression: a brain wave study

This study tests whether a single dose of ketamine can change brain wave patterns (called gamma oscillations) in people with treatment-resistant depression. Researchers want to see if these brain waves can predict who will feel better after treatment.

Houston, Texas
NCT06278779Recruiting· Phase 4
Comparing two types of ketamine for stubborn depression

This study compares two forms of ketamine to see which works better for depression that hasn't improved with at least two other antidepressants. If you've tried multiple antidepressants without success, this trial might help find a more effective treatment.

Camperdown, New South Wales

Hear when a new Treatment Resistant Depression (TRD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.